Clinical Research Directory
Browse clinical research sites, groups, and studies.
Functional Image-Guided Carbon Ion Irradiation With Simultaneous Integrated Boost for Prostate Cancer
Sponsor: Shanghai Proton and Heavy Ion Center
Summary
This is a phase II randomized controlled clinical trial to assess the toxicities and clinical efficacy of prostate specific membrane antigen (PSMA) positron emission tomography / computed tomography (PET/CT) and multi- parameter Magnetic Resonance Imaging (MRI) guided simultaneous integrated boost for prostate cancer.
Official title: Functional Image-Guided Carbon Ion Irradiation With Simultaneous Integrated Boost for Prostate Cancer: a Phase II Randomized Controlled Clinical Trial
Key Details
Gender
MALE
Age Range
45 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
140
Start Date
2020-10-15
Completion Date
2028-07-01
Last Updated
2021-11-15
Healthy Volunteers
No
Conditions
Interventions
carbon ion irradation
All patients will receive carbon ion irradiation with 65.6 GyE in 16 fractions to the prostate with or without seminal vesicle
Carbon Ion Irradiation With SIB
All patients will receive carbon ion irradiation with 65.6 GyE in 16 fractions to the prostate with or without seminal vesicle, and with simultaneous integrated boost (SIB) to the gross tumor in the PSMA PET/CT and mpMRI
Locations (1)
Shanghai Proton and Heavy Ion Center
Shanghai, China